Leaflet FERRIPROX 500mg film-coated tablets

Product code:
W51518001
Quantity:
100
Indicated for:
iron overload
Route of administration:
oral
Substance:
deferiprone (chelating agent)
ATC
V03AC02 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents
Deferiprone is an iron chelator used for the treatment of chronic iron overload in patients with major thalassemia, particularly when other treatments are not suitable. It works by binding excess iron, facilitating its elimination through urine.

The medication is taken orally, usually three times daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, vomiting, joint pain, and neutropenia.

Deferiprone is contraindicated in patients with severe neutropenia, active infections, or hypersensitivity to the active substance. Its use also requires regular monitoring of blood counts to prevent hematological complications.

This medication is an important option for patients with iron overload, helping to reduce the risk of complications associated with this condition.

General data about FERRIPROX 500mg

Substance:
deferiprone
Date of latest medicines list:
01-07-2015
Product code:
W51518001
Concentration:
500mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for deferiprone

Concentrations available for deferiprone

  • 100mg/ml
  • 500mg